Clinical Trials Logo

Clinical Trial Summary

Observational study that will be collecting clinical and molecular health information from cancer patients who have received comprehensive genomic profiling and meet the specific eligibility criteria outlined for each cohort with the goal of conducting research to advance cancer care and create a dataset that furthers cancer research.


Clinical Trial Description

The Study will collect combined clinical and molecular health information for cancer patients in the United States from multiple academic medical centers and community oncology practices. Participants who agree to join the Study will have their molecular profiling results, associated clinical health information, and longitudinal outcomes health information collected by the participating Institution for submission to Tempus. The specific goal of the Study is to create an outcomes-based dataset for future research to improve cancer treatment. ;


Study Design


Related Conditions & MeSH terms

  • Bile Duct Neoplasms
  • Bladder Cancer
  • Bone Neoplasms
  • Brain Cancer
  • Brain Neoplasms
  • Breast Cancer
  • Cancer of Cervix
  • Cancer of Colon
  • Cancer of Endometrium
  • Cancer of Esophagus
  • Cancer of Gastrointestinal Tract
  • Cancer of Head and Neck
  • Cancer of Kidney
  • Cancer of Larynx
  • Cancer of Liver
  • Cancer of Rectum
  • Cancer of Skin
  • Cancer of Stomach
  • Cancer of the Bile Duct
  • Carcinoma, Renal Cell
  • Colonic Neoplasms
  • Endometrial Neoplasms
  • Esophageal Neoplasms
  • Fallopian Tube Cancer
  • Fallopian Tube Neoplasms
  • Gastrointestinal Neoplasms
  • Head and Neck Neoplasms
  • Kidney Neoplasms
  • Laryngeal Neoplasms
  • Leukemia
  • Liver Neoplasms
  • Lung Cancer
  • Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Peritoneal Cancer
  • Prostate Cancer
  • Rectal Neoplasms
  • Skin Neoplasms
  • Spinal Cord Cancer
  • Stomach Neoplasms
  • Uterine Cervical Neoplasms
  • Vulvar Neoplasms

NCT number NCT05179824
Study type Observational
Source Tempus AI
Contact PRIORITY Study
Phone (833) 514-4187
Email prioritystudy@tempus.com
Status Recruiting
Phase
Start date October 19, 2020
Completion date October 19, 2030

See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A